Jennifer L Taubert
CIK 1745938 · EVP, WWC. Innovative Medicine · last filed 2026-02-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$36.17M
Companies
3
Total Filings
35
Lifetime Open-Market Net
-$32.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON (JNJ.WD) Delisted | EVP, WWC. Innovative Medicine | 194,451 | — | — | -$19.32M | 11 | 2026-02-18 |
| MCD | Director | — | $284.81 | — | $0 | 13 | 2026-01-05 |
| JNJ | EVP, WW Chair, Pharmaceuticals | 150,159 | $240.87 | $36.17M | -$13.60M | 11 | 2023-02-15 |
Recent Filings · Page 4 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-10 | JNJ | Grant (A) | — | $0 | EDGAR |
| 2020-02-18 | JNJ | Mixed | +7,856 | -$1.24M | EDGAR |
| 2020-02-12 | JNJ | Grant (A) | — | $0 | EDGAR |
| 2020-02-04 | JNJ | Mixed | +24,591 | -$3.54M | EDGAR |
| 2019-02-12 | JNJ | Mixed | +10,075 | -$1.29M | EDGAR |
Showing 31–35 of 35
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.